Gw Pharmaceuticals Plc experienced detoriation of Annual Capital Expenditures for the fiscal year ended 2020 by 0% to $ 18.75 millions, compare to $ 18.75 in Annual Capital Expenditures reported in the previous year. Gw Pharmaceuticals Plc's Capital Expenditures decline slowed form -43.87 % contraction in the fiscal year 2019.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com